SCS
PTLA

Syquant Capital SAS’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

Syquant Capital SAS’s Portfolio PTLA Stock Details PTLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-267,327
Closed -$4.81M – 76
2020
Q2 		$4.81M Buy
+267,327
New +$3.72M 2.24% 9

Syquant Capital SAS's PTLA Position: Q3 2020 in Review

Syquant Capital SAS sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q3 2020, closing a stake of 267,327 shares — an estimated $4.81M sold.

Syquant Capital SAS first reported a position in PTLA in Q2 2020 and held it in 1 quarter. The position peaked at $4.81M in Q2 2020. 0 funds tracked by Wall St. Rank hold PTLA as of Q3 2020.

  • Syquant Capital SAS reported no remaining Portola Pharmaceuticals, Inc. position as of Q3 2020 after selling out during the quarter.
  • Syquant Capital SAS sold 267,327 Portola Pharmaceuticals, Inc. shares in Q3 2020, an estimated $4.81M.
  • Syquant Capital SAS first reported a position in Portola Pharmaceuticals, Inc. in Q2 2020 and held it in 1 quarter.
  • Syquant Capital SAS's Portola Pharmaceuticals, Inc. position peaked at $4.81M in Q2 2020.
  • 0 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q3 2020.

Based on Syquant Capital SAS's 13F filing for Q3 2020, filed 21 Oct 2020.